Merck, Ridgeback seek US clearance of first oral COVID-19 drug
Healthcare
Source: healthcaredive.com
Page 37 - Umer Raffat News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Umer Raffat Today - Breaking & Trending Today
Merck to buy Acceleron for $11.5B; cardio drug could cushion fall from Keytruda cliff
Merck is looking for products that diversify its portfolio beyond reliance on cancer drug Keytruda, and it sees a potential blockbuster cardiovascular drug from Acceleron Pharma as fitting the bill. The pharma giant is paying $11.5 billion to acquire the biotech, and executives say they’re still on the hunt for more deals.
Source: medcitynews.com
Athenex, inc (ATNX) Q2 2021 Earnings Call Transcript
ATNX earnings call for the period ending June 30, 2021.
Source: fool.com
Biogen's Alzheimer's drug could cost Medicare billions of dollars a year, report finds
Biogen's new Alzheimer's drug, Aduhelm, could cost Medicare billions of dollars a year, according to an analysis by the nonprofit Kaiser Family Foundation.
Source: msn.com